Numerous investigators in the selenium field have proposed that low molecular weight selenocompounds are responsible for the numerous health benefits attributed to selenium, while others have suggested that selenoproteins are likely responsible. These health benefits include preventing cancer, heart disease and other cardiovascular and muscle disorders, inhibiting viral expression, delaying the progression of AIDS in HIV positive patients, slowing the aging process and having roles in mammalian development, male reproduction and immune function. We proposed several years ago that these health benefits are due largely to the presence of selenium in selenoproteins as the amino acid, selenocysteine (Sec). Therefore, to elucidate the role of selenoproteins in cancer prevention and development, we are characterizing the function of several selenoproteins. During the past year, we have focused our attention on studying in greater detail the role of three selenoproteins, thioredoxin peroxidase 1 (TR1), glutathione peroxidase 4 (GPx4) and selenoprotein 15 (Sep15). We had previously shown that the knockdown of TR1 using RNA interference technology in a lung cancer cell line (JBC 281: 13005, 2006) and in a cancer cell line driven by oncogenic k-ras (PLoS One 2: e1112;1-7, 2007) resulted in several of the malignant phenotypes being reversed more towards those of normal cells suggesting that TR1 deficiency is antitumorigenic. This past year, we have continued to focus on the molecular basis of TR1s role in cancer development and have examined the role of TR1 in apoptosis in a breast cancer cell line in detail. The breast cancer cell line was selected since we found that TR1 knockdown in breast cancer cells showed a much higher sensitivity to TNF-alpha induced apoptosis. We are currently confirming these findings in mice in vivo as further discussed in Project 1 (Z01 BC 005317). We are also continuing our study on the intracellular role of GPx4 and have found GPx4 is essential for repairing membrane lipid hydroperoxidation. Furthermore, we have evidence that this selenoprotein may be involved in the etiology of neurodegenerative diseases such as Alzheimers and Parkinsons diseases. GPx4 has decreased levels in brain tissue of Alzheimers and Parkinsons disease mouse models. GPx4 is a selenium-containing, antioxidant enzyme whose intracellular function has not been fully resolved. To elucidate its function intracellularly, we targeted the removal of GPx4 in a mouse fibroblast cell line (NIH3T3 cells) that resulted in severe damage to the cells when the level of this enzyme was reduced below 80% of its normal level. Partial reduction in its expression led to severe growth retardation. Unexpectedly, GPx4 knockdown cells showed little change in levels of reactive oxygen species, but these cells manifested highly increased levels of oxidized lipid byproducts suggesting membrane lipid hydroperoxidation damage. The data thus far have established an essential role of GPx4 in the metabolism of membrane lipid hydroperoxides, and surprisingly, a limited role as a general antioxidant enzyme. In the past year, we have found that Sep15 appears to have a role in colorectal cancer. Our findings demonstrate that knocking down the expression of Sep15 in the murine colon carcinoma cell line, CT-26, using RNAi resulted in phenotypic changes more towards normal cells that included decreased cell growth rates and reduced anchorage-independent growth abilities. Furthermore, CT-26, Sep15 knockdown cells, when injected into mice of the same background and compared to plasmid-transfected controls, also demonstrated a significantly reduced ability to form localized subcutaneous tumors and lung metastases in vivo. Mouse Lewis lung carcinoma cells (LLC1), transfected with the same siSep15 construct, appeared to maintain their original growth characteristics, indicating that knockdown of Sep15 reduced tumorigenicity of colon (CT26), but not lung (LLC1) cells. We are continuing to investigate this apparent tissue specificity, as well as possible functions of Sep15 in colon and other tissues.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
1ZIABC010889-02
Application #
7965801
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
2009
Total Cost
$304,554
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
Zip Code
Naranjo-Suarez, Salvador; Carlson, Bradley A; Tsuji, Petra A et al. (2012) HIF-independent regulation of thioredoxin reductase 1 contributes to the high levels of reactive oxygen species induced by hypoxia. PLoS One 7:e30470
Tobe, Ryuta; Yoo, Min-Hyuk; Fradejas, Noelia et al. (2012) Thioredoxin reductase 1 deficiency enhances selenite toxicity in cancer cells via a thioredoxin-independent mechanism. Biochem J 445:423-30
Lee, Byung Cheon; Lobanov, Alexey V; Marino, Stefano M et al. (2011) A 4-selenocysteine, 2-selenocysteine insertion sequence (SECIS) element methionine sulfoxide reductase from Metridium senile reveals a non-catalytic function of selenocysteines. J Biol Chem 286:18747-55
Kasaikina, Marina V; Fomenko, Dmitri E; Labunskyy, Vyacheslav M et al. (2011) Roles of the 15-kDa selenoprotein (Sep15) in redox homeostasis and cataract development revealed by the analysis of Sep 15 knockout mice. J Biol Chem 286:33203-12
Shim, Myoung Sup; Kim, Jin Young; Lee, Kwang Hee et al. (2011) l(2)01810 is a novel type of glutamate transporter that is responsible for megamitochondrial formation. Biochem J 439:277-86
Shchedrina, Valentina A; Everley, Robert A; Zhang, Yan et al. (2011) Selenoprotein K binds multiprotein complexes and is involved in the regulation of endoplasmic reticulum homeostasis. J Biol Chem 286:42937-48
Malinouski, Mikalai; Zhou, You; Belousov, Vsevolod V et al. (2011) Hydrogen peroxide probes directed to different cellular compartments. PLoS One 6:e14564
Irons, Robert; Tsuji, Petra A; Carlson, Bradley A et al. (2010) Deficiency in the 15-kDa selenoprotein inhibits tumorigenicity and metastasis of colon cancer cells. Cancer Prev Res (Phila) 3:630-9
Yoo, Min-Hyuk; Carlson, Bradley A; Tsuji, Petra et al. (2010) Alteration of thioredoxin reductase 1 levels in elucidating cancer etiology. Methods Enzymol 474:255-75
Hatfield, Dolph L; Yoo, Min-Hyuk; Carlson, Bradley A et al. (2009) Selenoproteins that function in cancer prevention and promotion. Biochim Biophys Acta 1790:1541-5

Showing the most recent 10 out of 16 publications